Comparing Cost-Effectiveness of First-Line Treatment Approaches for Hodgkin Lymphoma
Of 5 treatment regimens assessed, a PET-adapted de-escalation treatment approach was found to be the most cost-effective in 87% of cases modelled.
Of 5 treatment regimens assessed, a PET-adapted de-escalation treatment approach was found to be the most cost-effective in 87% of cases modelled.
Most men would not have chosen a different treatment even if they had been aware of costs.
A clinic-based technique of targeted biopsy using MRI and ultrasound may improve the diagnosis and management of prostate cancer.
Use of the oral antidiabetes drug metformin improved survival in women with ovarian cancer, according to the findings of a retrospective case-control study.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
An intrauterine device releasing the progestin levonorgestrel was effective therapy for early endometrial cancer in women not fit for surgery.
An analysis of breath samples from patients with pulmonary nodules distinguished benign from malignant growths in a recent study.
Robotic-assisted laparoscopic radical prostatectomy exceeded the cost of open radical retropubic prostatectomy by almost $5,300 per case.
Six years after breast cancer treatment, more than 60% of women experienced at least one side effect amenable to rehabilitative intervention.
Robotic-assisted laparoscopic radical cystectomy (RARC) results in fewer problems and deaths than open cystectomy, but lengths of stay are similar and RARC costs more.